Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
12,683
datasets available to search
ShareScore release 0.9.0
Dataset results
12,683 results for “tolerability”
A Phase 1, Randomized, Placebo-Controlled Safety and Tolerability Study Of Intravenous SBS-1000 in Healthy Adults
ClinicalTrials.gov study NCT05721287. IPD Sharing: NO. Countries: 1. Publications: 0.
Long-term Safety and Tolerability of MY008211A Tablets in Patients With Paroxysmal Nocturnal Hemoglobinuria
ClinicalTrials.gov study NCT06933914. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN and Severe Proteinuria
ClinicalTrials.gov study NCT04456816. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of the Tolerance, Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of MIL62 Injection for Treating Lupus Nephritis
ClinicalTrials.gov study NCT07044115. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Long-term Safety, Tolerability and Efficacy of Idebenone in Duchenne Muscular Dystrophy (DELPHI Extension)
ClinicalTrials.gov study NCT00758225. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study To Investigate The Safety, Tolerability And Blood Levels Of GSK598809
ClinicalTrials.gov study NCT00437840. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Open Label, Dose Escalating Study to Evaluate the Safety and Tolerability of Ascending Intravenous (i.v.) Doses of Catumaxomab in Epithelial Cancer Patients
ClinicalTrials.gov study NCT01320020. IPD Sharing: Not stated. Countries: 3. Publications: 0.
A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of BBM-D101 in the Treatment of Duchenne Muscular Dystrophy.
ClinicalTrials.gov study NCT07058662. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase I Clinical Study for Evaluation of Pharmacokinetic, Safety, Tolerance of Norcantharidin Lipid Microsphere for Injection in Patients With Solid Tumor
ClinicalTrials.gov study NCT04673396. IPD Sharing: NO. Countries: 1. Publications: 0.
Growth and Tolerance of Young Infants Fed Infant Formulas
ClinicalTrials.gov study NCT01380886. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Investigate the Pharmacokinetics (PK), Tolerability and Safety of Two Different Dupilumab Drug Products in Healthy Participants.
ClinicalTrials.gov study NCT05976373. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Determine Optimal Dose and Evaluate Safety, Tolerability, and Pharmacokinetics of Progerinin in Patients With Hutchinson-Gilford Progeria Syndrome (HGPS)
ClinicalTrials.gov study NCT06775041. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (P
ClinicalTrials.gov study NCT05662202. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of [225Ac]Ac-PSMA-XT Injection in Patients With Metastatic Castration-resistant Prostate Cancer
ClinicalTrials.gov study NCT07135102. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Evaluating the Safety, Tolerability, PK, and Activity of Topical ATx201 Gel in Outpatients With Impetigo
ClinicalTrials.gov study NCT03429595. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Tolerability of Deucravacitinib in the Management of Palmoplantar Pustulosis
ClinicalTrials.gov study NCT07000630. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study to Determine the Safety and Tolerability of Varenicline (Chantix®) in Treating Spinocerebellar Ataxia Type 3
ClinicalTrials.gov study NCT00992771. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effects of Yangxinshi Pills on the Exercise Tolerance of the Patients With Coronary Heart Disease
ClinicalTrials.gov study NCT03478332. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Safety, Tolerability and Pharmacokinetics of 0.5% and 2.5% Cis-UCA Eye Drops in Adult Healthy Volunteers (Phase I)
ClinicalTrials.gov study NCT01476332. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, Tolerability, Effect of Vildagliptin and How the Body Changes the Blood Level of Vildagliptin in Healthy Chinese Volunteers
ClinicalTrials.gov study NCT00419887. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.